Skip to content

Evaluation of Efficacy of Lumbar Plexus Bloc After Hip Surgery

Study of Posterior Lumbar Plexus Block for Pain Relief After Hip Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00150865
Enrollment
60
Registered
2005-09-08
Start date
2001-09-30
Completion date
2002-03-31
Last updated
2017-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative

Keywords

ropivacaine, posterior lumbar plexus block, hip arthroplasy, analgesia, postoperative

Brief summary

Compare lumbar plexus block with ropivacaine 0.475%, 0.4 ml/kg to saline. Each group randomized, includes 30 patients. block performed preoperatively Surgery under general anesthesia. Postoperative evaluation of pain (VAS) as first endpoint, and also morphine consumption via PCA device. Follow-up : 24h. Expectation : sizeable reduction of pain with block, of duration.

Detailed description

Compare lumbar plexus block (randomized) * ropivacaine 0.475%, 0.4 ml/kg * saline 0.4 ml/kg . Each group includes 30 patients. Block performed preoperatively. Surgery under general anesthesia (sufentanil, propofol, atracurium ; maintenance : sevoflurane and nitrous oxide in O2. Sufentanil added peroperatively as clinically needed. Postoperative evaluation of pain (VAS, by an independant blind observer) as first endpoint, and also morphine consumption via PCA device. Adverse effects (nausea, vomiting, etc) recorded Follow-up : 24h. Expectation : sizeable reduction of pain with block, of duration.

Interventions

DRUGropivacaine

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adults * ASA 1-3

Exclusion criteria

* cognitive impairement * ASA IV

Design outcomes

Primary

MeasureTime frame
decrease of postoperative pain

Secondary

MeasureTime frame
decrease in morphine consumption
duraration of analgesic effect

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026